Akeso Advances "IO 2.0 + ADC 2.0" Strategy with Phase II Initiation of Novel ADCs Combined with Ivonescimab and Cadonilimab
PR Newswire
Today at 2:40am UTC
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Camping World Holdings, Inc. to Secure Counsel Before Important Deadline in Securities Class...
GlobeNewswire
Today at 2:36am UTC
ConsumerDirect Takes Stand to Protect Intellectual Property and Trade Secrets
PR Newswire
Today at 2:35am UTC
From SCAN to SPARK: Galaxy Brain Scientific Enables a New Paradigm in Non-invasive, Personalized Precision Treatment for Parkinson's Disease
PR Newswire
Today at 2:34am UTC
/C O R R E C T I O N -- Coco Robotics/
PR Newswire
Today at 2:19am UTC
Money talks: investor turnout to set record
PR Newswire
Today at 2:13am UTC
PowerSteering: A New Standard for Financial Accountability
Press Services
Today at 2:10am UTC
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at...
GlobeNewswire
Today at 2:09am UTC
Trip.com Group Limited Securities Fraud Class Action Result of Antitrust Probe and 19% Stock Decline - Investors may Contact Lewis Kahn, Esq...
GlobeNewswire
Today at 2:08am UTC
Gartner, Inc. Securities Fraud Class Action Result of Reduced Guidance Disclosure and 48% Stock Decline - Investors may Contact Lewis Kahn,...
GlobeNewswire
Today at 2:07am UTC
Driven Brands Holdings Inc. Securities Fraud Class Action Result of Erroneous Financial Statements and 39% Stock Decline - Investors may...
GlobeNewswire
Today at 2:06am UTC
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact...
GlobeNewswire
Today at 2:05am UTC
Apollo Global Management, Inc. Securities Fraud Class Action Result of Undisclosed Relationship with Jeffrey Epstein and 16% Stock Decline -...
GlobeNewswire
Today at 2:05am UTC
Rogers Communications Inc. Announces Pricing of Public Offering of US$750 million Fixed-to-Fixed Rate Subordinated Notes and Canadian...
GlobeNewswire
Today at 2:05am UTC
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn...
GlobeNewswire
Today at 2:04am UTC
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick &...
GlobeNewswire
Today at 2:03am UTC
Navan, Inc. Notice of April 24, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC,...
GlobeNewswire
Today at 2:02am UTC
AIxCrypto Holdings Reports Full Year 2025 Financial Results; Highlights Transformational Pivot to AI and Blockchain Infrastructure
PR Newswire
Today at 2:01am UTC
Kyndryl Holdings, Inc. Notice of April 13, 2026 Application Deadline for Class Action Lawsuits - Contact Lewis Kahn, Esq. at Kahn Swick &amp...
GlobeNewswire
Today at 2:01am UTC
Hitem3D Integrates with OpenClaw Agent Workflows Through Skill-Based API Orchestration
PR Newswire
Today at 2:00am UTC